does glp-1 cause blood clots Clots? Evidence and Safety – Bolt Pharmacy Can GLP-1 Medications Be Considered

TRT Dosage Guide: Finding Your Optimal Testosterone Protocol Complete clinical guide to testosterone replacement therapy dosing starting doses, adjustment timelines, injection frequency optimization, and common dosing mistakes to avoid

Side Effects of Qsymia for Weight Loss The most common side effects, reported by 5% or more of patients, include: Paresthesia (tingling in hands, feet, or face), reported by about 20% of patients Dry mouth Insomnia , especially if taken later in the day Dizziness Constipation Taste changes , particularly with carbonated drinks Mood changes , including irritability or low mood Difficulty concentrating or brain fog with higher doses of topiramate Less common but more serious risks include: Increased heart rate Acute glaucoma (rare, but requires immediate discontinuation) Kidney stones Birth defects (Qsymia is in a Risk Evaluation and Mitigation Strategy or REMS program, due to teratogenicity risk) Qsymia should not be used during pregnancy, in patients with glaucoma, hyperthyroidism or those taking MAOIs

Stekovic, S

Some patients benefit from the ability to adjust doses more frequently or combine medications, which may be more readily available through online services

Medicare Advantage claims follow a CMS-mandated 12-month floor

Research news A recent meta-analysis presented at the European Congress on Obesity has found that glucagon-like peptide-1 receptor agonists and related multi-hormone obesity drugs were associated with lower systolic blood pressure in adults living with overweight or obesity A meta-analysis of 32 phase III studies involving 43,618 adults has found that contemporary obesity drugs used for weight loss were associated with a clinically relevant reduction in blood pressure, with systolic blood pressure reported to fall by 0.34 millimetres of mercury for each 1 per cent reduction in body weight